Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,586 | 11,560 | 7,851 | 16,926 | 22,465 |
| TOTAL | $10,764 | $11,938 | $8,458 | $17,657 | $22,665 |
| Non-Current Assets | |||||
| PPE Net | 13,906 | 13,911 | 13,916 | 13,921 | 13,924 |
| Other Non-Current Assets | 250 | 284 | 18 | 18 | 18 |
| TOTAL | $14,156 | $14,195 | $13,934 | $13,939 | $13,942 |
| Total Assets | $24,920 | $26,133 | $22,392 | $31,596 | $36,607 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 804 | 700 | 875 | 6,393 | 8,603 |
| Accrued Expenses | 803 | 483 | 1,343 | 2,022 | 1,751 |
| TOTAL | $1,774 | $1,340 | $2,218 | $8,415 | $10,354 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 82 | 128 | 0 | 0 | 0 |
| TOTAL | $82 | $128 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,856 | $1,468 | $2,218 | $8,415 | $10,354 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22 | 22 | 22 | 17 | 17 |
| Common Shares | 4 | 4 | 3 | 3 | 3 |
| Retained earnings | -249,917 | -246,433 | -241,551 | -237,741 | -233,949 |
| TOTAL | $23,064 | $24,665 | $20,174 | $23,181 | $26,253 |
| Total Liabilities And Equity | $24,920 | $26,133 | $22,392 | $31,596 | $36,607 |